Glaucoma Treatment Medications

Glaucoma is an eye disease that involves increased pressure within your eyeball, usually caused by fluid build-up.

2012-10-28

CHICAGO, IL, October 28, 2012 (Press-News.org) Glaucoma is an eye disease that involves increased pressure within your eyeball, usually caused by fluid build-up. This pressure can eventually damage to your eye's optic nerve, leading to progressive vision loss. Glaucoma is the second leading cause of blindness in the United States. Treatment can take a variety of forms, depending on the type and extent of your glaucoma.

Types of Glaucoma Eye Drops

The most common treatment for glaucoma involves specialized eye drops that are designed to decrease the amount of fluid (called "aqueous humor") in your eye - or at least improve the fluid's outward flow. Sometimes, a combination of different types of eye drops is prescribed for the best results.

Your ophthalmologist should thoroughly inform you of the purpose of your eye drops and any potential side effects, since these eye drops can have serious side effects if they are misused.

The main glaucoma eye drop medications are as follows:

- Beta blockers - Lower your eye pressure by limiting the production of fluid and reducing the rate at which the fluid flows into your eyes. Examples: Betagan, Ocupress, Timoptic.
- Alpha adrenergic agonists - Reduce production of fluid in your eye, and increase the rate at which it flows out of your eyes. Examples: Iopidine, Alphagan, Gluacon, Propine.
- Carbonic anhydrase inhibitors - Reduce production of fluid in your eye. Comes in both eye drop form and pill form. Examples: Trusopt, Azopt, Diamox, Neptazane.
- Prostaglandin analogs - Increase the outward flow of eye fluid. Examples: Zioptan, Xalatan, Lumigan, Travatan.
- Miotics - Make your pupil smaller in diameter; increase the rate of eye fluid drainage. Examples: Isopto Carpine, Pilocar, Pilopine.

Some medications involve combinations of the above medication types, such as Cosopt, Xalacom, and Combigan.

Laser Eye Surgery

Eye drops are not the only option for glaucoma treatment. Laser eye surgery can also be used to improve open-angle or angle-closure glaucoma. After your eye has been numbed, a laser will be used on the tissue near your cornea and iris that is responsible for draining the fluid from your eye into your bloodstream. Using laser energy, an experienced ophthalmologist can reduce the level of pressure in your eye.

Laser surgery cannot permanently cure glaucoma, but it can significantly improve your condition for a number of years. Continued medication through eye drops or pills may be necessary, but in lower amounts.

If you have further questions about glaucoma treatment, please visit the website of experienced Chicago eye doctor Dr. Mark Golden at Doctors For Visual Freedom today at www.doctorsforvisualfreedom.com.

ELSE PRESS RELEASES FROM THIS DATE:

The America Invents Act Is a Game Changer for Patent Seekers

2012-10-28

In what one attorney called the "most important change to patent laws since Thomas Jefferson wrote patent laws into the Constitution," the first portion of the America Invents Act, or AIA, went into effect in September 2012. The AIA's major component will go into effect in March 2013. While the AIA had bipartisan support, including that of the Obama administration, only time will tell the true impact of these sweeping changes. A patent is an exclusive property right granted to an inventor by the United States Patent and Trademark Office, known as the USPTO. ...

Distracted Driving Remains a Major Threat in Los Angeles

2012-10-28

Many Los Angeles residents are all too familiar with the sight of drivers who are more focused on their cellphones than on the road. In a busy metropolitan area like Los Angeles, the risks of texting while driving are particularly high -- and yet the phenomenon remains alarmingly common. Distracted Driving by the Numbers According to a study by the National Highway Transportation Safety Administration and the Virginia Tech Transportation Institute, distracted driving plays a role in 80 percent of U.S. traffic crashes and 65 percent of near-misses. While all types ...

Models developed from the PLCO may help identify at-risk patients for adverse smoking outcomes

2012-10-27

Risk prediction models developed from an ancillary study of the Prostate Lung Colorectal and Ovarian Cancer Screening Trial (PLCO) may be useful in the public health sector for identifying individuals who are at risk for adverse smoking outcomes, such as relapse among former smokers and continued smoking among current smokers, and those who may benefit from relapse prevention and smoking cessation interventions according to a study published October 26 in the Journal of the National Cancer Institute. With a projected 226,160 new cases of lung cancer and 160,340 lung ...

NASA sees Hurricane Sandy as the "Bride of Frankenstorm" approaching the US East Coast

2012-10-27

VIDEO: An animation of NOAA's GOES-13 satellite observations from Oct. 24-26, 2012, shows Hurricane Sandy crossing eastern Cuba and moving through and exiting the Bahamas. This visualization was created by the... Click here for more information. NASA's TRMM satellite revealed Hurricane Sandy's heavy rainfall and the storm is expected to couple with a powerful cold front and Arctic air to bring that heavy rainfall to the Mid-Atlantic and northeastern U.S. Some forecasters ...

Results of the STEMI-RADIAL trial presented at TCT 2012

2012-10-27

MIAMI, FL – OCTOBER 26, 2012 – A study found several benefits in using the radial artery in the arm as the entry point for angioplasty or percutaneous coronary intervention (PCI) compared to the femoral artery in the leg. Results of the STEMI-RADIAL trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. Recent data have demonstrated better clinical ...

Nanotechnology helps scientists keep silver shiny

2012-10-27

There are thousands of silver artifacts in museum collections around the world, and keeping them shiny is a constant challenge. So scientists are using new technology to give conservators a helping hand. A team of researchers led by Ray Phaneuf, a professor of materials science and engineering at the University of Maryland, College Park, has partnered with The Walters Art Museum in Baltimore to investigate less labor-intensive ways to protect silver artifacts from tarnishing. The new techniques, which might keep silver surfaces shiny for longer than traditional methods, ...

Scientists build 'nanobowls' to protect catalysts needed for better biofuel production

2012-10-27

It may sound like a post-season football game for very tiny players, but the "nanobowl" has nothing to do with sports and everything to do with improving the way biofuels are produced. That's the hope of a team of scientists from the Institute for Atom Efficient Chemical Transformations (IACT), an Energy Frontier Research Center led by Argonne National Laboratory (ANL), and including Northwestern University, the University of Wisconsin and Purdue University. The team is using a layering technique developed for microchip manufacturing to build nanoscale (billionth of a meter) ...

Scientists demonstrate high-efficiency quantum dot solar cells

2012-10-27

Research shows newly developed solar powered cells may soon outperform conventional photovoltaic technology. Scientists from the National Renewable Energy Laboratory (NREL) have demonstrated the first solar cell with external quantum efficiency (EQE) exceeding 100 percent for photons with energies in the solar range. (The EQE is the percentage of photons that get converted into electrons within the device.) The researchers will present their findings at the AVS 59th International Symposium and Exhibition, held Oct. 28 — Nov. 2, in Tampa, Fla. While traditional semiconductors ...

Princess by proxy: When child beauty pageants aren't about the kids

2012-10-27

As child reality TV star Honey Boo Boo continues to capture the attention of audiences with her boisterous personality and her own show about life on the child beauty pageant circuit, a new paper published today in the Journal of the American Academy of Child and Adolescent Psychiatry takes a critical look at the very types of pageants in which she and thousands of other children compete in America every year. The paper, authored by Martina M. Cartwright, a registered dietician and adjunct professor in the University of Arizona's department of nutritional sciences, suggests ...

Scientists use molecular layers to study nanoscale heat transfer

2012-10-27

Scientific research has provided us with a fundamental understanding of how light (via photons) and electricity (via electrons) move within and between materials at the micrometer or nanometer levels, making possible a wide variety of miniature devices such as transistors, optical sensors and microelectromechanical systems (MEMS). However, man's knowledge of micro- and nanoscale heat flow is rudimentary at best. Now, a research team at the University of Illinois at Urbana-Champaign (UIUC) has developed a novel system for examining and measuring nanoscale thermal conductance ...

University Hospitals Seidman Cancer Center becomes first in the United States to implement Akesis Inc. innovative Galaxy RTI device for patient treatment

Tailored hard/soft magnetic heterostructure anchored on 2D carbon nanosheet for efficient microwave absorption and anti-corrosion property

A novel strategy for modulating the crystalline-amorphous composites and electronic structure to enhance hydrogen evolution reaction

Metal-free catalysts break through in green H2O2 synthesis! Novel organic semiconductors enable high-efficiency interfacial reactions

Do these two cancer drugs have what it takes to beat Alzheimer’s?

[Press-News.org] Glaucoma Treatment Medications
Glaucoma is an eye disease that involves increased pressure within your eyeball, usually caused by fluid build-up.

Glaucoma Treatment Medications

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: